Oramed Pharmaceuticals (ORMP) Receivables (2011 - 2018)
Oramed Pharmaceuticals (ORMP) reported Receivables of $65000.0 for Q1 2018, little changed quarter-over-quarter from $65000.0 in Q4 2017.
Oramed Pharmaceuticals (ORMP) Receivables (2011 - 2018) Analysis & Trends
Oramed Pharmaceuticals has reported Receivables for 8 years, with the latest figure at $65000.0 in Q1 2018.
- For the quarter ending Q1 2018, Receivables changed N/A year-over-year to $65000.0; the trailing twelve-month figure through Feb 2018 stood at $65000.0 (changed N/A YoY), and the FY2017 full-year result was $65000.0, changed 0.0% from the prior year.
- Receivables for Q1 2018 stood at $65000.0, roughly flat from $65000.0 in the prior quarter.
- The five-year high for Receivables was $2.2 million in Q2 2015, with the low at $65000.0 in Q3 2015.
- Historically, Receivables has averaged $253485.8 across 5 years, with a median of $65000.0 in 2015.
- Annual changes were most pronounced in 2015 — Receivables jumped 560.18% — and 2016, when it tumbled 97.04%.
- Oramed Pharmaceuticals' Receivables stood at $92000.0 in 2014, then fell by 29.35% to $65000.0 in 2015, then changed by 0.0% to $65000.0 in 2016, then changed by 0.0% to $65000.0 in 2017, then changed by 0.0% to $65000.0 in 2018.
- The last three Receivables figures came in at $65000.0 (Q1 2018), $65000.0 (Q4 2017), and $65000.0 (Q3 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2018 | 65,000.00 |
| Nov 30, 2017 | 65,000.00 |
| Aug 31, 2017 | 65,000.00 |
| Nov 30, 2016 | 65,000.00 |
| Aug 31, 2016 | 65,000.00 |
| May 31, 2016 | 65,000.00 |
| Feb 29, 2016 | 65,000.00 |
| Nov 30, 2015 | 65,000.00 |
| Aug 31, 2015 | 65,000.00 |
| May 31, 2015 | 2.19 Mn |
| Feb 28, 2015 | 67,000.00 |
| Nov 30, 2014 | 92,000.00 |
| Aug 31, 2014 | 395,000.00 |
| May 31, 2014 | 332,184.00 |
| Feb 28, 2014 | 138,103.00 |
| Nov 30, 2013 | 65,053.00 |
| May 31, 2013 | 512,519.00 |
| Feb 28, 2013 | 539,286.00 |
| Nov 30, 2012 | 175,483.00 |
| Aug 31, 2012 | 172,333.00 |